Caribou Biosciences, Inc. (CRBU) Social Stream



Caribou Biosciences, Inc. (CRBU): $5.80

0.14 (+2.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRBU to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Caribou Biosciences Inc (CRBU) Price Targets From Analysts

Use the tables below to see what analysts covering Caribou Biosciences Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 3 $33 $27 $30.666 $9.34 228.33%
2021-11-15 3 $33 $27 $30.666 $9.34 228.33%
2021-11-30 5 $33 $27 $30 $9.34 221.2%
2022-01-28 5 $36 $27 $31.2 $9.34 234.05%
2022-02-14 6 $36 $19 $29.166 $9.34 212.27%
2022-03-21 7 $36 $19 $27.714 $9.34 196.72%

The Trend in the Analyst Price Target


Over the past 28 weeks, CRBU's average price target has gone down $1.53.

CRBU reports an average of 95.91% for its upside potential over the past 28 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 3 33 27 30.666 21.16 44.92%
2021-12-01 5 36 27 31.200 16.93 84.29%
2022-01-28 6 36 27 31.200 10.31 202.62%
2022-01-28 5 36 27 31.200 10.31 202.62%
2022-03-21 7 36 19 28.142 9.15 207.56%

CRBU Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.14 6 1 0 0 0 7

The Trend in the Broker Recommendations


Over the past 90 days, CRBU's average broker recommendation rating worsened by 0.14.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRBU as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Caribou Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 799.53% of them.
  • Caribou Biosciences Inc's variance in analysts' estimates is lower than -339.71% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Caribou Biosciences Inc's number of analysts covering the stock is higher than 613.57% of them.
  • In the context of stocks in the small market cap category, Caribou Biosciences Inc's average analyst price target is higher than 609.64% of them.

In the Pharmaceutical Products industry, CMPI, CLLS, and CHRS are the three stocks most similar to Caribou Biosciences Inc regarding the price target and analyst recommendation information presented here.

Is CRBU a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6757 seconds.